Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000261274 | SCV000330877 | likely benign | not provided | 2020-05-01 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001855076 | SCV002248960 | likely benign | Noonan syndrome 9 | 2024-07-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436096 | SCV002751172 | uncertain significance | Cardiovascular phenotype | 2021-10-13 | criteria provided, single submitter | clinical testing | The p.N993I variant (also known as c.2978A>T), located in coding exon 19 of the SOS2 gene, results from an A to T substitution at nucleotide position 2978. The asparagine at codon 993 is replaced by isoleucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |